Staging preview: health content pending qualified review

Melanotan 2 10 mg

Also searched as: melanotan ii, mt2 peptide, melanotan

Sold as MT2 (Melanotan 2) - 10mg

$35 In stock

Strength
Ships from

For research use only. Not for human or veterinary use.

Ships from the USA or Canada. Shipping details

Melanotan 2 (Melanotan II, MT2) is a lab-made peptide of 7 amino acids closed into a ring, modeled on the hormone alpha-MSH.1 It switches on several melanocortin receptors, and in small trials it darkened skin but also caused erections, nausea and yawning.234 The vial holds 10 mg of white freeze-dried powder.5 MT2 is not FDA approved for any use.6

Specifications

Sequence (three-letter code)Ac-Nle-Cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH27
StructureCyclic heptapeptide: 7 amino acids, with a lactam bridge closing the ring from Asp to Lys; acetylated start, amide end17
Molecular formulaC50H69N15O98
Molar mass1024.2 g/mol8
CAS number121062-08-69
PubChem CID924328
FormWhite freeze-dried (lyophilized) powder, per the supplier's specification5
Vial contents10 mg per vial
Strength10 mg
Ships fromUSA, Canada
CategoriesCollagen Peptides, Sexual Health Peptides
StorageThe supplier lists a shelf life of 36 months at -20 °C and 30 days at 2 to 8 °C, without saying whether the 30-day figure applies to the dry powder or to a mixed vial.5

Bulk and wholesale orders

Labs ordering Melanotan II in volume, or wanting one Melanotan II supplier across repeat orders, can apply for a wholesale account. Melanotan II wholesale terms are confirmed on application.

Questions about Melanotan 2

About Melanotan 2

Melanotan 2 was developed at the University of Arizona as one of a family of long-acting, enzyme-resistant melanocortin analogs. Of the two tested in people, Melanotan 1 is a straight chain and MT2 a shortened ring.15161 MT2's effect on erections was discovered by accident during studies of skin tanning.17 It is a non-selective melanocortin receptor agonist: it darkens skin mainly through MC1R on pigment cells, while in rodents its appetite-suppressing effect is thought to run through MC4R.2181924

This page lists Melanotan II for sale as a 10 mg research vial. The controlled human studies we found are small University of Arizona trials published from 1996 to 2000: 3 healthy men in a pilot study and 20 men with erectile dysfunction in crossover trials.202 If you plan to buy Melanotan II online for lab work, What is Melanotan 2? covers side effects, regulatory history and the published research.

Research highlights

  • Skin darkening (1996, pilot phase 1 trial, n=3): two of three healthy men had measurably darker skin on the face, upper body and buttock 1 week after a 2-week course of injections under the skin, with MT2 alternating with saline.320
  • Erections (1998, double-blind crossover trial, n=10): 8 of 10 men with psychogenic erectile dysfunction had clinically apparent erections, with tip rigidity above 80% for 38.0 minutes on average on MT2 versus 3.0 on placebo.21
  • Desire and nausea (2000 review of both crossover trials, n=20): increased sexual desire followed 68% of MT2 doses and 19% of placebo doses, and 12.9% of subjects had severe nausea at one dose level.2223
  • Heart rate and blood pressure (2012, mice): systemic MT2 raised both in a dose-dependent way, heart rate more than pressure, and an MC3/MC4 receptor blocker abolished the effect.25
  • Moles (2019 systematic review, 179 published patients): immunosuppressants, chemotherapy or melanotan, counted as one group, were the suspected cause in 41% of sudden-onset mole cases; the data could not assess the risk of malignant change.2627

Regulatory status

FDA has not approved MT2 for any use, and in 2007 it warned a company selling Melanotan II as a tanning agent and skin cancer preventive.613 FDA's compounding safety page (current as of April 2026) lists Melanotan II among substances once in category 2 whose nominators withdrew them, and warns that compounded forms may pose a risk of immune reactions for certain routes, from aggregation or peptide-related impurities.2829 Its Pharmacy Compounding Advisory Committee is to discuss Melanotan II for the 503A bulks list at a meeting before the end of February 2027.3031 In April 2024 the UK's MHRA said injectable and pen Melanotan II products are medicines, and that UK law does not permit the sale, supply or advertising of unauthorized medicines.3233

Handling and storage

The vial holds MT2 as a white freeze-dried solid with no diluent.512 Peptides often absorb water from the air, so peptide maker Bachem advises warming a cold vial to room temperature in a desiccator before opening it.34 Bachem also notes that peptides containing tryptophan, as MT2 does, have limited shelf lives.357 Mixing steps are in the reconstitution guide, and the reconstitution calculator works out the concentration for a chosen volume of bacteriostatic water.

Frequently asked questions

Where does Melanotan II ship from?

Orders ship from the USA and Canada to addresses across the United States. The selector at the top of this page shows the stock status for each shipping origin before you add the vial to your cart. Delivery details are on the shipping page and return terms on the returns page.

How should Melanotan II be stored when it arrives?

Freeze-dried peptides can travel at room temperature. For longer storage, peptide maker Bachem advises a tightly closed container below -15 °C, with a refrigerator at 4 °C for short-term use.35 The supplier rates this vial for 36 months at -20 °C and 30 days at 2 to 8 °C.5 General steps are in How to store peptides.

What strength is the vial, and what is the Melanotan II price?

Melanotan II is sold as a 10 mg vial of freeze-dried powder, from $35. The price and stock badge at the top of the page update when you pick a shipping origin. The vial holds powder only, so bacteriostatic water is a separate item.12

Is there a certificate of analysis for Melanotan II?

The lab documents we publish are on the lab results page. The supplier's posted certificate for lot 2025-02-13 reports 99.20% purity by HPLC-UV-MS, but it does not state how many milligrams the vial holds.10 That gap matters: a 2015 lab study of MT2 vials that online shops sold as 10 mg found 4.32 to 8.84 mg.11

What supplies go with a Melanotan II vial?

The vial holds powder only; bacteriostatic water is not included.12 The supplies listed with it are bacteriostatic water, a 3 mL Luer-Lok syringe, an 18G 1-inch needle, insulin syringes and alcohol swabs. These are lab handling items, not directions for use in people.

Is Melanotan II for human use?

No. It is sold for laboratory research only and labeled not for human or veterinary use. FDA has not approved MT2 for any use, and in 2007 it advised consumers using a Melanotan II product to stop.6 FDA's compounding safety page notes published case reports of serious harms, including melanoma and priapism.14

Written by D2C Peptides Editorial Team.

Pending qualified review.

Updated .

Sources

  1. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study (Dorr et al., PMID 8637402). Life Sciences, 1996.
  2. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II (Wessells et al., PMID 11035391), design excerpt. International Journal of Impotence Research, 2000.
  3. Same source as 1: pigmentation excerpt.
  4. Same source as 1: side effects excerpt.
  5. Supplier product specification.
  6. FDA Fast Facts: FDA Warns Melanotan II Maker (US Pharm. 2007;32(10):72), warning letter excerpt. U.S. Pharmacist, 2007.
  7. Melanotan II, PubChem CID 92432: synonyms. PubChem (NCBI, U.S. National Library of Medicine), 2026.
  8. melanotan-II, PubChem CID 92432: computed properties. PubChem (NCBI, U.S. National Library of Medicine), 2026.
  9. Melanotan II, PubChem CID 92432: CAS number (PUG View). PubChem (NCBI, U.S. National Library of Medicine), 2026.
  10. Supplier certificate of analysis.
  11. Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet (Breindahl et al., PMID 24771717), content excerpt. Drug Testing and Analysis, 2015.
  12. Same source as 5.
  13. Same source as 6: FDA statement excerpt.
  14. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of 04/22/2026), Melanotan II case reports entry. U.S. Food and Drug Administration, 2026.
  15. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization (Hadley and Dorr, PMID 16412534), design excerpt. Peptides, 2006.
  16. Same source as 15: MT1 vs MT2 excerpt.
  17. Discovery that a melanocortin regulates sexual functions in male and female humans (Hadley, PMID 15996790), discovery excerpt. Peptides, 2005.
  18. Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report (Bonchev, PMID 41752902), mechanism excerpt. Life (Basel), 2026.
  19. Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats (Trivedi et al., PMID 12834882), background excerpt. Brain Research, 2003.
  20. Same source as 1: design excerpt.
  21. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study (Wessells et al., PMID 9679884), results excerpt. The Journal of Urology, 1998.
  22. Same source as 2: desire excerpt.
  23. Same source as 2: nausea excerpt.
  24. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome (Fan et al., PMID 8990120). Nature, 1997.
  25. Hemodynamic actions and mechanisms of systemically administered alpha-MSH analogs in mice (Rinne et al., PMID 22982611). Peptides, 2012.
  26. Eruptive Melanocytic Nevi: A Review (Burian and Jemec, PMID 31119650), causes excerpt. American Journal of Clinical Dermatology, 2019.
  27. Same source as 26: limitation excerpt.
  28. Same source as 14: withdrawn list heading.
  29. Same source as 14: Melanotan II immunogenicity entry.
  30. Meeting of the Pharmacy Compounding Advisory Committee (content current as of 04/15/2026), timing. U.S. Food and Drug Administration, 2026.
  31. Same source as 30: agenda.
  32. FOI 24/274: Side effects reports of melanotan II products (17 April 2024), classification. Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK, 2024.
  33. Same source as 32: legal status.
  34. Care and Handling of Peptides. Bachem, 2021.
  35. Handling and Storage Guidelines for Peptides (Peptide Guide, chapter 8). Bachem.